Zoetis Treasury Stock increased by 5.6% to $11.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.1%, from $7.89B to $11.29B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 36.8% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.57B | $2.76B | $2.95B | $3.32B | $3.77B | $4.14B | $4.54B | $4.81B | $5.13B | $5.37B | $5.60B | $5.93B | $6.46B | $6.89B | $7.45B | $7.89B | $8.23B | $8.61B | $10.69B | $11.29B |
| QoQ Change | — | +7.4% | +7.0% | +12.4% | +13.5% | +9.9% | +9.7% | +5.9% | +6.6% | +4.7% | +4.2% | +5.9% | +9.0% | +6.6% | +8.1% | +6.0% | +4.3% | +4.6% | +24.2% | +5.6% |
| YoY Change | — | — | — | — | +46.7% | +50.0% | +53.8% | +44.9% | +36.1% | +29.7% | +23.3% | +23.3% | +26.1% | +28.3% | +33.0% | +33.1% | +27.3% | +24.9% | +43.5% | +43.1% |